Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. In two clinical studies, Kynmobi (apomorphine hydrochloride) was associated with greater and faster motor improvement than was levodopa among…
News
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Carbidopa/levodopa enteral suspension (CLES) provided long-term, sustained, and clinically meaningful reductions in “off” time for people with Parkinson’s disease, according…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Tasigna (nilotinib), an approved leukemia medication, was seen to be safe and tolerable at high…
PhotoPharmics plans to open, possibly this summer, a pivotal Phase 3 clinical trial of its light-based and noninvasive Celeste device in treating Parkinson’s symptoms, for use by patients at home and with trial goals evaluated using telemedicine. A particular company goal for this device, PhotoPharmics also announced, is reaching underserved patients…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. The investigational medication SEP-363856 might ease symptoms of Parkinson’s disease psychosis, according to data from a…
MedRhythms is launching a clinical trial of its experimental digital therapy MR-005, which seeks to use sensors, music, and software to improve walking ability in people with Parkinson’s disease and other neurological disorders. The technology, which received a patent in the United States last year, works by…
Zarela Martinez, a celebrity chef with Parkinson’s disease (PD), has partnered with Acorda Therapeutics to create a video series aimed at helping people live well with the progressive neurodegenerative disorder. Release of the series, called “A Taste for Life with Zarela,” coincides with Parkinson’s Awareness Month, observed each April.
An intensive and sweeping rehabilitation program, given in a hospital, led to significant short-term improvements in the functional and cognitive abilities of people with mild-to-moderate Parkinson’s disease in a recent study. That study, “Functional and Cognitive Improvement After an Intensive Inpatient Multidisciplinary Rehabilitation Program in Mild to…
Dorys, a 66-year-old woman with Parkinson’s who lives in Peru, was able to be treated for her progressive disease through an extreme sacrifice: the sale of her family’s home. Diagnosed 15 years earlier, the disease had rendered Dorys unable to do much of anything. Her physicians suggested a surgical treatment…
The parkin protein, whose mutated form is linked to certain cases of early onset Parkinson’s disease, protects neurons by lowering levels of potentially harmful oxidants, and by removing them from areas where they might do harm, a study reported. Exactly how parkin worked to help protect brain cells from this…
Recent Posts
- MJFF grants $6.9M to prepare OPM’s Parkinson’s therapy for clinical trial
- The invisible support a Parkinson’s caregiver provides
- US, China regulators OK trials of stem cell therapy in MSA-P
- When caregiver stress hits, I remember to have ‘just a little patience’
- Japan grants conditional approval to Amchepry cell therapy for Parkinson’s